Catapult Ventures

Catapult Ventures is one of the most experienced venture capital fund managers in the United Kingdom, founded in 1999 and headquartered in Leicester in the Midlands. The firm has successfully managed numerous discrete venture capital funds totaling approximately £130 million on behalf of public and private sector investors, completing 151 investments across its history. Key funds include the £30 million East Midlands Regional VC Fund, the £20 million West Midlands seed fund, the £30 million Catapult Growth Fund (an Enterprise Capital Fund), and the £31 million GM&C Life Sciences Fund for Greater Manchester and Cheshire. Catapult leads rounds at the Seed through Series B stages, deploying checks of £50,000 to £2 million across healthcare, life sciences, pharmaceuticals, software, and advanced manufacturing. The firm's exit track record demonstrates consistently strong multiples: R2C Online at 12.6x, Accutronics at 9.1x, Yospace at 6.9x, Oxford Cryosystems at 5.2x, Lumora at 4.7x, and Monica Healthcare at 3.6x. Other notable exits include Abzena, Left Hand Robotics, and Ergomed. The most recent investment was Array Labs at Series A in January 2026. Catapult Ventures combined operations with Opus Ventures in 2013, deepening its regional footprint and talent base. The firm's multi-decade presence in the UK Midlands — a region often underserved by London-centric capital — reflects a deliberate focus on building enduring companies from inception through exit across the full life sciences and technology innovation cycle.